-

GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will announce its fourth quarter and full year 2022 financial results before the market opens on Monday, January 30, 2023. The GE HealthCare management team will also host a conference call and webcast at 8:00 a.m. Eastern Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay will also all be posted at the same link on the GE HealthCare Investor Relations website.

About GE HealthCare

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to create a world where healthcare has no limits.

Contacts

GE HealthCare Investor Contact
Carolynne Borders
631.662.4317
carolynne.borders@gehealthcare.com

GE HealthCare Media Contact
Tor Constantino
585.441.1658
tor.constantino@gehealthcare.com

GE HealthCare

NASDAQ:GEHC

Release Versions

Contacts

GE HealthCare Investor Contact
Carolynne Borders
631.662.4317
carolynne.borders@gehealthcare.com

GE HealthCare Media Contact
Tor Constantino
585.441.1658
tor.constantino@gehealthcare.com

More News From GE HealthCare

GE HealthCare appoints William Grogan as Chief Financial Officer

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today announced the appointment of William (Bill) Grogan as Chief Financial Officer, effective September 14, 2026. Grogan succeeds Jay Saccaro, who, as previously announced, stepped down for an expanded role outside of the medical technology industry. George Newcomb, who is serving as interim Chief Financial Officer, will continue in his role as Controller and Chief Accounting Officer. Grogan join...

GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the introduction of the LOGIQ™ e family, featuring LOGIQ™ e Xi and LOGIQ™ e Si, two compact laptop ultrasound systems designed to help clinicians deliver simple, fast, and confident ultrasound imaging where it’s needed across care settings.ii Building on the legacy of LOGIQ e, the LOGIQ e family pairs a reliable console-level performance with a compact, intuitive design combining AI-powered featuresiii and workflow tools that support porta...

GE HealthCare expands breast imaging portfolio with Invenia ABUS Prime and launch of ABUS StreamVue

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced the launch of Invenia™ ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue™, a redesigned enterprise viewer that recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking, expanding its breast imaging portfolio with solutions designed to support supplemental screening for women with dense breasts and provide more flexible enterprise-wide exam review. Together, these new solutions aim to help breast i...
Back to Newsroom